Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial
At 5-year follow-up, TLF was comparable for EES and BES. The incidence of myocardial infarction, however, was lower in patients randomised to EES versus BES implantation.
Authors
- Karsten Tange Veien (ORCID: https://orcid.org/0000-0002-3898-9331)
- Christian Juhl Terkelsen (ORCID: https://orcid.org/0000-0003-0205-9551)
- Svend Eggert Jensen (ORCID: https://orcid.org/0000-0002-0348-8668)
- Evald Høj Christiansen (ORCID: https://orcid.org/0000-0002-8740-4862)
- Michael Mæng (ORCID: https://orcid.org/0000-0002-4310-6433)
- Lars Jakobsen (ORCID: https://orcid.org/0000-0002-2522-9253)
- Troels Thim (ORCID: https://orcid.org/0000-0002-1014-5559)
- Rebekka Vibjerg Jensen (ORCID: https://orcid.org/0000-0001-6539-5275)
- Lisette Okkels Jensen (ORCID: https://orcid.org/0000-0002-4838-2429)
- Phillip Freeman (ORCID: https://orcid.org/0000-0003-1769-251X)
- Ashkan Eftekhari (ORCID: https://orcid.org/0000-0003-2871-8279)
- Steen Dalby Kristensen
- Bent Raungaard
- Nicolaj Brejnholt Støttrup
- Johnny Kahlert
Institutions
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- EuroIntervention
- Published
- 2025-05-26
- DOI
- https://doi.org/10.4244/eij-d-24-00763
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00